MicroRNAs and Toll-like receptor/interleukin-1 receptor signaling

Journal of Hematology and Oncology

Volumn 5, Issue , 2012, Pages

  Virtue, Anthony ^a   Wang, Hong ^a   Yang, Xiao Feng ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Interleukin 1 receptor; MicroRNAs; mRNA stability; Toll like receptors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE 2; MICRORNA; MYELOID DIFFERENTIATION FACTOR 88; RIBOSOME RNA; SMALL INTERFERING RNA; SMALL NUCLEAR RNA; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

3' UNTRANSLATED REGION; CRYPTOSPORIDIUM PARVUM; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; RIBOSOME; RNA SEQUENCE; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INTERLEUKIN-1; MICRORNAS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84867534932     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-5-66     Document Type: Review

References (148)

1. Finishing the euchromatic sequence of the human genome. Nature 2004 431 931 945
2. MicroRNAs: target recognition and regulatory functions. Bartel DP, Cell 2009 136 215 233
3. Origins and Mechanisms of miRNAs and siRNAs. Carthew RW, Sontheimer EJ, Cell 2009 136 642 655
4. The widespread regulation of microRNA biogenesis, function and decay. Krol J, Loedige I, Filipowicz W, Nature reviews 2010 11 597 610
5. Origin, biogenesis, and activity of plant microRNAs. Voinnet O, Cell 2009 136 669 687
6. MicroRNA biogenesis: coordinated cropping and dicing. Kim VN, Nat Rev Mol Cell Biol 2005 6 376 385 (Pubitemid 40637855)
7. MicroRNA maturation: stepwise processing and subcellular localization. Lee Y, Jeon K, Lee JT, Kim S, Kim VN, EMBO J 2002 21 4663 4670 (Pubitemid 34984353)
8. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP, Mol Cell 2007 27 91 105 (Pubitemid 46991392)
9. Principles of microRNA-target recognition. Brennecke J, Stark A, Russell RB, Cohen SM, PLoS Biol 2005 3 85
10. Combinatorial microRNA target predictions. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N, Nat Genet 2005 37 495 500 (Pubitemid 40617277)
11. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Lewis BP, Burge CB, Bartel DP, Cell 2005 120 15 20 (Pubitemid 40094598)
12. Prediction of mammalian microRNA targets. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB, Cell 2003 115 787 798 (Pubitemid 38058492)
13. Specificity of microRNA target selection in translational repression. Doench JG, Sharp PA, Genes Dev 2004 18 504 511 (Pubitemid 38372808)
14. PARalyzer: definition of RNA binding sites from PAR-CLIP short-read sequence data. Corcoran DL, Georgiev S, Mukherjee N, Gottwein E, Skalsky RL, Keene JD, Ohler U, Genome Biol 2011 12 79
15. Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. Nielsen CB, Shomron N, Sandberg R, Hornstein E, Kitzman J, Burge CB, RNA 2007 13 1894 1910 (New York, NY) (Pubitemid 350005216)
16. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB, Bartel DP, Science 2005 310 1817 1821 (New York, NY) (Pubitemid 41814382)
17. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM, Nature 2005 433 769 773 (Pubitemid 40292988)
18. Pervasive regulation of Drosophila Notch target genes by GY-box-, Brd-box-, and K-box-class microRNAs. Lai EC, Tam B, Rubin GM, Genes Dev 2005 19 1067 1080 (Pubitemid 40632452)
19. Distance constraints between microRNA target sites dictate efficacy and cooperativity. Saetrom P, Heale BS, Snove O Jr, Aagaard L, Alluin J, Rossi JJ, Nucleic Acids Res 2007 35 2333 2342 (Pubitemid 47073716)
20. Crystal structure of Argonaute and its implications for RISC slicer activity. Song JJ, Smith SK, Hannon GJ, Joshua-Tor L, Science 2004 305 1434 1437 New York, NY (Pubitemid 39167656)
21. Argonaute proteins: key players in RNA silencing. Hutvagner G, Simard MJ, Nat Rev Mol Cell Biol 2008 9 22 32
22. Argonaute2 is the catalytic engine of mammalian RNAi. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ, Science 2004 305 1437 1441 New York, NY (Pubitemid 39167657)
23. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T, Mol Cell 2004 15 185 197 (Pubitemid 38950966)
24. Domains in gene silencing and cell differentiation proteins: the novel PAZ domain and redefinition of the Piwi domain. Cerutti L, Mian N, Bateman A, Trends Biochem Sci 2000 25 481 482
25. Structure and nucleic-acid binding of the Drosophila Argonaute 2 PAZ domain. Lingel A, Simon B, Izaurralde E, Sattler M, Nature 2003 426 465 469 (Pubitemid 37490135)
26. Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain. Ma JB, Ye K, Patel DJ, Nature 2004 429 318 322 (Pubitemid 38684819)
27. The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes. Song JJ, Liu J, Tolia NH, Schneiderman J, Smith SK, Martienssen RA, Hannon GJ, Joshua-Tor L, Nat Struct Biol 2003 10 1026 1032 (Pubitemid 37500495)
28. Structure and conserved RNA binding of the PAZ domain. Yan KS, Yan S, Farooq A, Han A, Zeng L, Zhou MM, Nature 2003 426 468 474
29. Structural basis for 5'-end-specific recognition of guide RNA by the A. fulgidus Piwi protein. Ma JB, Yuan YR, Meister G, Pei Y, Tuschl T, Patel DJ, Nature 2005 434 666 670 (Pubitemid 40488561)
30. Crystal structure of a PIWI protein suggests mechanisms for siRNA recognition and slicer activity. Parker JS, Roe SM, Barford D, EMBO J 2004 23 4727 4737 (Pubitemid 40069703)
31. Crystal structure of A. aeolicus argonaute, a site-specific DNA-guided endoribonuclease, provides insights into RISC-mediated mRNA cleavage. Yuan YR, Pei Y, Ma JB, Kuryavyi V, Zhadina M, Meister G, Chen HY, Dauter Z, Tuschl T, Patel DJ, Mol Cell 2005 19 405 419 (Pubitemid 41078780)
32. MicroRNA directs mRNA cleavage of the transcription factor NAC1 to downregulate auxin signals for arabidopsis lateral root development. Guo HS, Xie Q, Fei JF, Chua NH, Plant Cell 2005 17 1376 1386 (Pubitemid 43138191)
33. MicroRNA control of PHABULOSA in leaf development: importance of pairing to the microRNA 5' region. Mallory AC, Reinhart BJ, Jones-Rhoades MW, Tang G, Zamore PD, Barton MK, Bartel DP, EMBO J 2004 23 3356 3364 (Pubitemid 39209159)
34. MicroRNA-directed cleavage of HOXB8 mRNA. Yekta S, Shih IH, Bartel DP, Science 2004 304 594 596 (New York, NY) (Pubitemid 38541919)
35. A microRNA as a translational repressor of APETALA2 in Arabidopsis flower development. Chen X, Science 2004 303 2022 2025 New York, NY (Pubitemid 38393278)
36. The enzymes and control of eukaryotic mRNA turnover. Parker R, Song H, Nat Struct Mol Biol 2004 11 121 127 (Pubitemid 38146514)
37. Control of translation and mRNA degradation by miRNAs and siRNAs. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R, Genes Dev 2006 20 515 524 (Pubitemid 43345317)
38. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM, Cell 2003 113 25 36 (Pubitemid 36411957)
39. miR-15 and miR-16 induce apoptosis by targeting BCL2. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et al. Proc Natl Acad Sci USA 2005 102 13944 13949 (Pubitemid 41377683)
40. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Lee RC, Feinbaum RL, Ambros V, Cell 1993 75 843 854 (Pubitemid 24014542)
41. A pancreatic islet-specific microRNA regulates insulin secretion. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, Stoffel M, Nature 2004 432 226 230 (Pubitemid 39545853)
42. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Wightman B, Ha I, Ruvkun G, Cell 1993 75 855 862 (Pubitemid 24014543)
43. Relief of microRNA-mediated translational repression in human cells subjected to stress. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W, Cell 2006 125 1111 1124 (Pubitemid 43866197)
44. MicroRNA silencing through RISC recruitment of eIF6. Chendrimada TP, Finn KJ, Ji X, Baillat D, Gregory RI, Liebhaber SA, Pasquinelli AE, Shiekhattar R, Nature 2007 447 823 828 (Pubitemid 46920131)
45. Repression of C. elegans microRNA targets at the initiation level of translation requires GW182 proteins. Ding XC, Grosshans H, EMBO J 2009 28 213 222
46. Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs. Gu S, Jin L, Zhang F, Sarnow P, Kay MA, Nat Struct Mol Biol 2009 16 144 150
47. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Mathonnet G, Fabian MR, Svitkin YV, Parsyan A, Huck L, Murata T, Biffo S, Merrick WC, Darzynkiewicz E, Pillai RS, et al. Science 2007 317 1764 1767 New York, NY (Pubitemid 47461843)
48. Human let-7a miRNA blocks protein production on actively translating polyribosomes. Nottrott S, Simard MJ, Richter JD, Nat Struct Mol Biol 2006 13 1108 1114 (Pubitemid 44885922)
49. Short RNAs repress translation after initiation in mammalian cells. Petersen CP, Bordeleau ME, Pelletier J, Sharp PA, Mol Cell 2006 21 533 542 (Pubitemid 43228008)
50. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, Basyuk E, Bertrand E, Filipowicz W, Science 2005 309 1573 1576 New York, NY (Pubitemid 41266485)
51. GW182 family proteins are crucial for microRNA-mediated gene silencing. Ding L, Han M, Trends Cell Biol 2007 17 411 416 (Pubitemid 47375102)
52. P-body formation is a consequence, not the cause, of RNA-mediated gene silencing. Eulalio A, Behm-Ansmant I, Schweizer D, Izaurralde E, Mol Cell Biol 2007 27 3970 3981 (Pubitemid 47010995)
53. How do microRNAs regulate gene expression? Cannell IG, Kong YW, Bushell M, Biochem Soc Trans 2008 36 1224 1231
54. An mRNA m7G cap binding-like motif within human Ago2 represses translation. Kiriakidou M, Tan GS, Lamprinaki S, De Planell-Saguer M, Nelson PT, Mourelatos Z, Cell 2007 129 1141 1151 (Pubitemid 46891041)
55. Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Kim J, Krichevsky A, Grad Y, Hayes GD, Kosik KS, Church GM, Ruvkun G, Proc Natl Acad Sci USA 2004 101 360 365 (Pubitemid 38084255)
56. The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Kong YW, Cannell IG, de Moor CH, Hill K, Garside PG, Hamilton TL, Meijer HA, Dobbyn HC, Stoneley M, Spriggs KA, et al. Proc Natl Acad Sci USA 2008 105 8866 8871
57. Evidence that microRNAs are associated with translating messenger RNAs in human cells. Maroney PA, Yu Y, Fisher J, Nilsen TW, Nat Struct Mol Biol 2006 13 1102 1107 (Pubitemid 44885921)
58. Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation. Thermann R, Hentze MW, Nature 2007 447 875 878 (Pubitemid 46920140)
59. Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways. Slack JL, Schooley K, Bonnert TP, Mitcham JL, Qwarnstrom EE, Sims JE, Dower SK, J Biol Chem 2000 275 4670 4678 (Pubitemid 30108853)
60. Innate immune recognition. Janeway CA Jr, Medzhitov R, Annu Rev Immunol 2002 20 197 216 (Pubitemid 34293424)
61. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. Smiley ST, King JA, Hancock WW, J Immunol 2001 167 2887 2894 (Pubitemid 32768923)
62. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR, Proc Natl Acad Sci USA 2002 99 2281 2286 (Pubitemid 34169052)
63. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW, Nat Immunol 2000 1 398 401
64. Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide- mimetic signal transduction by Taxol. Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, Nishijima M, J Biol Chem 2000 275 2251 2254 (Pubitemid 30081977)
65. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. Bulut Y, Faure E, Thomas L, Karahashi H, Michelsen KS, Equils O, Morrison SG, Morrison RP, Arditi M, J Immunol 2002 168 1435 1440 (Pubitemid 34094516)
66. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. Ohashi K, Burkart V, Flohe S, Kolb H, J Immunol 2000 164 558 561 (Pubitemid 30043672)
67. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al. Science 1998 282 2085 2088 (New York, NY (Pubitemid 29001265)
68. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA, Nature 2001 413 732 738 (Pubitemid 33009951)
69. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Ahmad-Nejad P, Hacker H, Rutz M, Bauer S, Vabulas RM, Wagner H, Eur J Immunol 2002 32 1958 1968 (Pubitemid 34814552)
70. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Heil F, Ahmad-Nejad P, Hemmi H, Hochrein H, Ampenberger F, Gellert T, Dietrich H, Lipford G, Takeda K, Akira S, et al. Eur J Immunol 2003 33 2987 2997 (Pubitemid 37428331)
71. Subcellular localization of Toll-like receptor 3 in human dendritic cells. Matsumoto M, Funami K, Tanabe M, Oshiumi H, Shingai M, Seto Y, Yamamoto A, Seya T, J Immunol 2003 171 3154 3162 (Pubitemid 37093540)
72. Fever: the old and the new. Atkins E, J Infect Dis 1984 149 339 348 (Pubitemid 14138235)
73. The biological properties of interleukin-1. Dinarello CA, Eur Cytokine Netw 1994 5 517 531
74. Toll-like receptor signalling. Akira S, Takeda K, Nature reviews 2004 4 499 511 (Pubitemid 38931765)
75. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. O'Neill LA, Bowie AG, Nature reviews 2007 7 353 364 (Pubitemid 46674493)
76. MyD88, an adapter protein involved in interleukin-1 signaling. Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, Di Marco F, French L, Tschopp J, J Biol Chem 1998 273 12203 12209 (Pubitemid 28240584)
77. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Janssens S, Beyaert R, Mol Cell 2003 11 293 302 (Pubitemid 36293825)
78. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. Wesche H, Gao X, Li X, Kirschning CJ, Stark GR, Cao Z, J Biol Chem 1999 274 19403 19410
79. Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase. Li X, Commane M, Burns C, Vithalani K, Cao Z, Stark GR, Mol Cell Biol 1999 19 4643 4652 (Pubitemid 29289502)
80. Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. Kanakaraj P, Schafer PH, Cavender DE, Wu Y, Ngo K, Grealish PF, Wadsworth SA, Peterson PA, Siekierka JJ, Harris CA, Fung-Leung WP, J Exp Med 1998 187 2073 2079 (Pubitemid 28285577)
81. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. Thomas JA, Allen JL, Tsen M, Dubnicoff T, Danao J, Liao XC, Cao Z, Wasserman SA, J Immunol 1999 163 978 984 (Pubitemid 29328110)
82. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, Takada H, Wakeham A, Itie A, Li S, et al. Nature 2002 416 750 756
83. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Li S, Strelow A, Fontana EJ, Wesche H, Proc Natl Acad Sci USA 2002 99 5567 5572 (Pubitemid 34411589)
84. TRAF6 is a signal transducer for interleukin-1. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV, Nature 1996 383 443 446 (Pubitemid 26330834)
85. Tumor necrosis factor receptor-associated factors (TRAFs). Bradley JR, Pober JS, Oncogene 2001 20 6482 6491 (Pubitemid 32977853)
86. Distinct molecular mechanism for initiating TRAF6 signalling. Ye H, Arron JR, Lamothe B, Cirilli M, Kobayashi T, Shevde NK, Segal D, Dzivenu OK, Vologodskaia M, Yim M, et al. Nature 2002 418 443 447 (Pubitemid 34826847)
87. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. Takaesu G, Surabhi RM, Park KJ, Ninomiya-Tsuji J, Matsumoto K, Gaynor RB, J Mol Biol 2003 326 105 115 (Pubitemid 36279361)
88. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K, Science 1996 272 1179 1182 New York, NY
89. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, Irie K, Ninomiya-Tsuji J, Matsumoto K, Mol Cell 2000 5 649 658
90. TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling. Sanjo H, Takeda K, Tsujimura T, Ninomiya-Tsuji J, Matsumoto K, Akira S, Mol Cell Biol 2003 23 1231 1238 (Pubitemid 36177033)
91. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. Ishitani T, Takaesu G, Ninomiya-Tsuji J, Shibuya H, Gaynor RB, Matsumoto K, EMBO J 2003 22 6277 6288 (Pubitemid 37522585)
92. Toll-like receptors. Takeda K, Kaisho T, Akira S, Annu Rev Immunol 2003 21 335 376 (Pubitemid 37174535)
93. Toll-like receptors and innate immunity. Medzhitov R, Nature reviews 2001 1 135 145 (Pubitemid 33741967)
94. Toll-like receptor signaling pathways. Barton GM, Medzhitov R, Science 2003 300 1524 1525 New York, NY (Pubitemid 36682871)
95. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. Moriguchi T, Kuroyanagi N, Yamaguchi K, Gotoh Y, Irie K, Kano T, Shirakabe K, Muro Y, Shibuya H, Matsumoto K, et al. J Biol Chem 1996 271 13675 13679 (Pubitemid 26187979)
96. ASK1 inhibits interleukin-1-induced NF-kappa B activity through disruption of TRAF6-TAK1 interaction. Mochida Y, Takeda K, Saitoh M, Nishitoh H, Amagasa T, Ninomiya-Tsuji J, Matsumoto K, Ichijo H, J Biol Chem 2000 275 32747 32752
97. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S, Koyasu S, Matsumoto K, Takeda K, Ichijo H, Nat Immunol 2005 6 587 592 (Pubitemid 41710729)
98. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y, Science 1997 275 90 94 New York, NY (Pubitemid 27020316)
99. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S, Science 2003 301 640 643 New York, NY (Pubitemid 36927946)
100. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T, Nat Immunol 2003 4 491 496 (Pubitemid 36592443)
101. Triggering the interferon antiviral response through an IKK-related pathway. Sharma S, TenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J, Science 2003 300 1148 1151 New York, NY (Pubitemid 36583100)
102. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Shimada T, Kawai T, Takeda K, Matsumoto M, Inoue J, Tatsumi Y, Kanamaru A, Akira S, Int Immunol 1999 11 1357 1362 (Pubitemid 29355675)
103. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. Pomerantz JL, Baltimore D, EMBO J 1999 18 6694 6704
104. IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex. Peters RT, Liao SM, Maniatis T, Mol Cell 2000 5 513 522
105. NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation. Nomura F, Kawai T, Nakanishi K, Akira S, Genes Cells 2000 5 191 202 (Pubitemid 30227841)
106. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, Takeuchi O, Takeda K, Akira S, Nat Immunol 2003 4 1144 1150 (Pubitemid 37428043)
107. Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT. Kimura A, Naka T, Muta T, Takeuchi O, Akira S, Kawase I, Kishimoto T, Proc Natl Acad Sci USA 2005 102 17089 17094 (Pubitemid 41692688)
108. Negative regulation of cytokine and TLR signalings by SOCS and others. Naka T, Fujimoto M, Tsutsui H, Yoshimura A, Adv Immunol 2005 87 61 122 (Pubitemid 41135899)
109. SOCS-1 participates in negative regulation of LPS responses. Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, Abe T, Seki E, Sato S, Takeuchi O, Takeda K, et al. Immunity 2002 17 677 687 (Pubitemid 35351512)
110. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Kinjyo I, Hanada T, Inagaki-Ohara K, Mori H, Aki D, Ohishi M, Yoshida H, Kubo M, Yoshimura A, Immunity 2002 17 583 591 (Pubitemid 35351504)
111. Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. Hanada T, Tanaka K, Matsumura Y, Yamauchi M, Nishinakamura H, Aburatani H, Mashima R, Kubo M, Kobayashi T, Yoshimura A, J Immunol 2005 174 4325 4332 (Pubitemid 40396015)
112. Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNgamma and IL-4 are involved. Chinen T, Kobayashi T, Ogata H, Takaesu G, Takaki H, Hashimoto M, Yagita H, Nawata H, Yoshimura A, Gastroenterology 2006 130 373 388 (Pubitemid 43202037)
113. Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling. Gingras S, Parganas E, de Pauw A, Ihle JN, Murray PJ, J Biol Chem 2004 279 54702 54707 (Pubitemid 40053214)
114. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist. Waiboci LW, Ahmed CM, Mujtaba MG, Flowers LO, Martin JP, Haider MI, Johnson HM, J Immunol 2007 178 5058 5068 (Pubitemid 46595289)
115. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Mansell A, Smith R, Doyle SL, Gray P, Fenner JE, Crack PJ, Nicholson SE, Hilton DJ, O'Neill LA, Hertzog PJ, Nat Immunol 2006 7 148 155 (Pubitemid 43135880)
116. SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation. He Y, Zhang W, Zhang R, Zhang H, Min W, J Biol Chem 2006 281 5559 5566 (Pubitemid 43847652)
117. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Neel BG, Gu H, Pao L, Trends Biochem Sci 2003 28 284 293 (Pubitemid 36776291)
118. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism. An H, Xu H, Zhang M, Zhou J, Feng T, Qian C, Qi R, Cao X, Blood 2005 105 4685 4692 (Pubitemid 40807290)
119. Absence of SHIP-1 results in constitutive phosphorylation of tank-binding kinase 1 and enhanced TLR3-dependent IFN-beta production. Gabhann JN, Higgs R, Brennan K, Thomas W, Damen JE, Ben Larbi N, Krystal G, Jefferies CA, J Immunol 2010 184 2314 2320
120. SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide. Sly LM, Rauh MJ, Kalesnikoff J, Buchse T, Krystal G, Exp Hematol 2003 31 1170 1181 (Pubitemid 37510021)
121. Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells. Chang J, Kunkel SL, Chang CH, Proc Natl Acad Sci USA 2009 106 18327 18332
122. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Androulidaki A, Iliopoulos D, Arranz A, Doxaki C, Schworer S, Zacharioudaki V, Margioris AN, Tsichlis PN, Tsatsanis C, Immunity 2009 31 220 231
123. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. Chen XM, Splinter PL, O'Hara SP, LaRusso NF, J Biol Chem 2007 282 28929 28938 (Pubitemid 47610421)
124. Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. Benakanakere MR, Li Q, Eskan MA, Singh AV, Zhao J, Galicia JC, Stathopoulou P, Knudsen TB, Kinane DF, J Biol Chem 2009 284 23107 23115
125. Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation. Tang B, Xiao B, Liu Z, Li N, Zhu ED, Li BS, Xie QH, Zhuang Y, Zou QM, Mao XH, FEBS Lett 2010 584 1481 1486
126. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Taganov KD, Boldin MP, Chang KJ, Baltimore D, Proc Natl Acad Sci USA 2006 103 12481 12486 (Pubitemid 44267285)
127. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. Hou J, Wang P, Lin L, Liu X, Ma F, An H, Wang Z, Cao X, J Immunol 2009 183 2150 2158
128. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF, Proc Natl Acad Sci USA 2010 107 13450- 13455
129. IFN-gamma and TNF-alpha synergistically induce microRNA-155 which regulates TAB2/IP-10 expression in human mesangial cells. Imaizumi T, Tanaka H, Tajima A, Yokono Y, Matsumiya T, Yoshida H, Tsuruga K, Aizawa-Yashiro T, Hayakari R, Inoue I, et al. Am J Nephrol 2010 32 462 468
130. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, Tanaka K, Loeb GB, Lee H, Yoshimura A, Rajewsky K, Rudensky AY, Immunity 2009 30 80 91
131. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Jiang S, Zhang HW, Lu MH, He XH, Li Y, Gu H, Liu MF, Wang ED, Cancer Res 2010 70 3119 3127
132. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. Wang P, Hou J, Lin L, Wang C, Liu X, Li D, Ma F, Wang Z, Cao X, J Immunol 2010 185 6226 6233
133. Inositol phosphatase SHIP1 is a primary target of miR-155. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D, Proc Natl Acad Sci USA 2009 106 7113 7118
134. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, Reilly J, Ierna M, Fraser AR, Stolarski B, et al. Proc Natl Acad Sci USA 2011 108 11193 11198
135. Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8. Bhattacharyya S, Balakathiresan NS, Dalgard C, Gutti U, Armistead D, Jozwik C, Srivastava M, Pollard HB, Biswas R, J Biol Chem 2011 286 11604 11615
136. Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a. Sharma A, Kumar M, Aich J, Hariharan M, Brahmachari SK, Agrawal A, Ghosh B, Proc Natl Acad Sci USA 2009 106 5761 5766
137. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA, Nat Immunol 2009 11 141 147
138. MicroRNA in TLR signaling and endotoxin tolerance. Nahid MA, Satoh M, Chan EK, Cell Mol Immunol 2011 8 388 403
139. MicroRNAs: the fine-tuners of Toll-like receptor signalling. O'Neill LA, Sheedy FJ, McCoy CE, Nature reviews 2011 11 163 175
140. MicroRNA-155 is induced during the macrophage inflammatory response. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D, Proc Natl Acad Sci USA 2007 104 1604 1609 (Pubitemid 46214637)
141. Regulation of the germinal center response by microRNA-155. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, et al. Science 2007 316 604 608 New York, NY (Pubitemid 46683147)
142. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J, Paquette RL, Baltimore D, J Exp Med 2008 205 585 594 (Pubitemid 351439306)
143. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Bazzoni F, Rossato M, Fabbri M, Gaudiosi D, Mirolo M, Mori L, Tamassia N, Mantovani A, Cassatella MA, Locati M, Proc Natl Acad Sci USA 2009 106 5282 5287
144. MicroRNAs in NF-kappaB signaling. Ma X, Becker Buscaglia LE, Barker JR, Li Y, J Mol Cell Biol 2011 3 159 166
145. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. Gao W, Shen H, Liu L, Xu J, Xu J, Shu Y, J Cancer Res Clin Oncol 2011 137 557 566
146. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Medina PP, Nolde M, Slack FJ, Nature 2010 467 86 90
147. NF-kappaB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses. Zhou R, Hu G, Liu J, Gong AY, Drescher KM, Chen XM, PLoS Pathog 2009 5 1000681
148. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Pasquinelli AE, Nature reviews 13 271 282